AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes.

Biomed Res Int · 2020 · PMC7439175 · PMID 32851091

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

The results indicated that the patients with the higher AURKA had a longer OS time in TP53 wild-type groups, although only a marginal significance was achieved due to the reduced number of samples.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.